The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs. [electronic resource]
Producer: 20180212Description: 79217-79232 p. digitalISSN:- 1949-2553
- Animals
- Antineoplastic Agents -- administration & dosage
- Azepines -- administration & dosage
- Cell Cycle Proteins
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Drug Synergism
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Mice
- NF-E2-Related Factor 2 -- metabolism
- Naphthoquinones -- administration & dosage
- Neuroblastoma -- drug therapy
- Nuclear Proteins -- metabolism
- Protein Domains -- drug effects
- RNA-Binding Proteins -- metabolism
- Small Molecule Libraries -- administration & dosage
- Transcription Factors -- metabolism
- Triazoles -- administration & dosage
- Tubulin Modulators -- administration & dosage
- Vincristine -- administration & dosage
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.